ArticleBMJ open2026
Understanding Australian healthcare provider attitudes towards smart inhalers for paediatric asthma management: a qualitative study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to explore the perceptions of Australian healthcare providers (HCPs) of the usefulness of smart inhalers for children with asthma and considerations for their effective integration into routine care.
designQualitative descriptive study using semi-structured interviews. A hybrid thematic analysis approach was used to analyse the data.
settingHealthcare services in Australia including general practice, hospitals and Local Health Districts.
participantsEight general practitioners, six paediatric specialists and nine respiratory nurses were recruited using a unique purposive sampling strategy for each HCP group. PRIMARY AND SECONDARY OUTCOME MEASURES: Perceptions of the facilitators and challenges to the adoption of smart inhalers for childhood asthma management.
resultsMost HCPs had not previously used smart inhalers. Perceived benefits of smart inhalers included access to objective medication use data to inform asthma treatment decisions and enable opportunities to discuss asthma management with parents and carers. Key facilitators for implementation included evidence of clinical effectiveness, financial incentives (both in terms of subsidised smart inhaler costs for users and reimbursement for HCPs) and integration of smart inhaler data into existing medical record systems. The primary barrier to implementation identified was related to workflow issues, including available resourcing, support and time.
conclusionsHCPs expressed generally positive views about the potential of smart inhalers to improve asthma management among children. However, they also identified several practical, logistical and clinical barriers that must be addressed prior to widespread implementation of smart inhalers. Targeted strategies that address these barriers will be essential for successful implementation into routine care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.